Core Viewpoint - The company expects to record a profit attributable to shareholders of approximately HKD 3 million to 5 million for the six months ending December 31, 2025, a decrease from HKD 11.6 million for the same period ending December 31, 2024 [1] Financial Performance - The anticipated decrease in profit is primarily due to a reduction in system sales revenue (including software licenses and services) by approximately HKD 5 million compared to the same period last year [1] - Contributing factors to the revenue decline include external factors such as weakened economic momentum in the UK, particularly delays in government procurement processes and budget approvals affecting tenders and contract awards in the UK public healthcare sector [1] - Additionally, distribution costs have increased by approximately HKD 2 million compared to the same period last year [1] Future Outlook - The company has observed a rebound in order volume at the beginning of 2026, including new contracts for the Multitone Nucleus cloud messaging solution awarded by several UK healthcare trust organizations [1]

Group 1 - The company expects to record a profit attributable to shareholders of approximately HKD 3 million to HKD 5 million for the six months ending December 31, 2025, compared to a profit of approximately HKD 11.6 million for the six months ending December 31, 2024 [1] - The decrease in profit is primarily due to a reduction in system sales revenue by approximately HKD 5 million, attributed to external factors such as weakened economic momentum in the UK and delays in government procurement processes [1] - Distribution costs have increased by approximately HKD 2 million compared to the same period last year [1] Group 2 - The company has observed a rebound in order volume at the beginning of 2026, including new contracts for the Multitone Nucleus cloud messaging solution awarded by several UK healthcare trusts [1] - As of February 12, 2026, the company's stock closed at HKD 0.42, down 1.16%, with a trading volume of 72,000 shares and a transaction value of HKD 30,700 [1] - The company's market capitalization is HKD 161 million, ranking 49th in the computer applications industry [2]

Core Viewpoint - The company expects to record a profit attributable to shareholders of approximately HKD 3 million to HKD 5 million for the six months ending December 31, 2025, a decrease from HKD 11.6 million for the same period ending December 31, 2024 [1] Financial Performance - The anticipated decrease in profit is primarily due to a reduction in system sales revenue (including software licenses and services) by approximately HKD 5 million compared to the same period last year [1] - The increase in distribution costs by approximately HKD 2 million compared to the same period last year also contributed to the decline in profit [1] Market Conditions - External factors such as a slowdown in the UK economy and delays in government procurement processes and budgets have impacted the public healthcare sector's tendering and contract awarding [1] - Recent observations indicate a rebound in order volume at the beginning of 2026, including new contracts for the Multitone Nucleus cloud messaging solution awarded by several UK healthcare trust organizations [1]